HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

por Shi, Xiaoqing, Ding, Jiage, Zheng, Yanyan, Wang, Jiawei, Sobhani, Navid, Neeli, Praveen, Wang, Gang, Zheng, Junnian, Chai, Dafei
Publicado 2023

Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models

por Zhang, Qing, Zhang, Haixu, Ding, Jiage, Liu, Hongyan, Li, Huizhong, Li, Hailong, Lu, Mengmeng, Miao, Yangna, Li, Liantao, Zheng, Junnian
Publicado 2018

Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”

por Zhang, Qing, Zhang, Haixu, Ding, Jiage, Liu, Hongyan, Li, Huizhong, Li, Hailong, Lu, Mengmeng, Miao, Yangna, Li, Liantao, Zheng, Junnian
Publicado 2019

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity

por Chai, Dafei, Qiu, Dong, Shi, Xiaoqing, Ding, Jiage, Jiang, Nan, Zhang, Zichun, Wang, Jiawei, Yang, Jie, Xiao, Pengli, Wang, Gang, Zheng, Junnian
Publicado 2021

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy

por Chai, Dafei, Shi, Shang Yuchen, Sobhani, Navid, Ding, Jiage, Zhang, Zichun, Jiang, Nan, Wang, Gang, Li, Minle, Li, Hailong, Zheng, Junnian, Bai, Jin
Publicado 2022

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma

por Jiang, Nan, Zheng, Yanyan, Ding, Jiage, Wang, Jiawei, Zhu, Fei, Wang, Meng, Sobhani, Navid, Neeli, Praveen, Wang, Gang, Li, Hailong, Zheng, Junnian, Chai, Dafei
Publicado 2023

Co‐immunization with L‐Myc enhances CD8(+) or CD103(+) DCs mediated tumor‐specific multi‐functional CD8(+) T cell responses

por Chai, Dafei, Zhang, Zichun, Jiang, Nan, Ding, Jiage, Qiu, Dong, Shi, Shang Yuchen, Wang, Gang, Fang, Lin, Li, Huizhong, Tian, Hui, Yang, Jie, Zhang, Qing, Zheng, Junnian
Publicado 2021

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8(+) T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

por Zheng, Yanyan, Lu, Zheng, Ding, Jiage, Jiang, Nan, Wang, Jiawei, Yang, Jie, Song, Jingyuan, Chen, Hongliang, Fang, Lin, Li, Huizhong, Tian, Hui, Wang, Gang, Zheng, Junnian, Chai, Dafei
Publicado 2022